United States · FDA National Drug Code directory
Methocarbamol Tablets, USP, 750 mg
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72789-521_4db4d9af-87e7-dce7-e063-6294a90acd01
- Product NDC
- 72789-521
- Form
- TABLET, FILM COATED
- Composition / generic term
- Methocarbamol
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250610
- Source listing expiry
- 20271231
Source-listed ingredients
- METHOCARBAMOL — 750 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-521-20) · 72789-521-20
- 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-521-30) · 72789-521-30
- 40 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-521-40) · 72789-521-40
- 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-521-60) · 72789-521-60
- 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-521-82) · 72789-521-82
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →